Q72: Marrow Evaluation

*Marrow evaluation
This section is only completed for Skysona® infusions.

*CIBMTR Study CS20-51
The Laboratory Studies (3502) and Marrow Surveillance (3506) forms will only come due for Skysona® infusions enrolled in CIBMTR study CS20-51.

Question 72: Was a marrow aspirate and / or biopsy performed?

Indicate Yes or No if a marrow aspirate and or biopsy was performed prior to the preparative regimen (or prior to infusion if no preparative regimen was given). Report the most recent marrow evaluation, and complete the Laboratory Studies (3502) Form and Marrow Surveillance (3506) Form. The intent is to screen for and/or identify changes in the marrow such as dysplasia, MDS, or new hematologic malignancy

Report Unknown if not documented.

Section Updates:

Question Number	Date of Change	Add/Remove/Modify	Description	Reasoning (If applicable)
Q72	4/24/2026	Add	CIBMTR Study CS20-51 blue note box added: CIBMTR Study CS20-51: The Laboratory Studies (3502) and Marrow Surveillance (3506) forms will only come due for Skysona® infusions enrolled in CIBMTR study CS20-51.	Added for clarification
Q72	10/25/2024	Modify	Marrow Evaluation blue box updated to clarify when this section is completed: This section is only completed for gene therapy Skysona® infusions. Report the marrow results at last evaluation prior to the start of the preparative regimen.	Due to change in validations

Copyright © 2004-2025 The Medical College of Wisconsin, Inc. and NMDP. All Rights Reserved.
CIBMTR® (Center for International Blood and Marrow Transplant Research) is a research collaboration between the Medical College of Wisconsin and NMDP.